Selecting treatments: a decision theoretic approach

被引:43
作者
Claxton, K
Lacey, LF
Walker, SG
机构
[1] Univ London Imperial Coll Sci Technol & Med, London, England
[2] Univ York, York YO1 5DD, N Yorkshire, England
[3] Glaxo Wellcome, Uxbridge, Middx, England
关键词
budget constraint; cost-benefit; cost effectiveness; marginal programme; utility;
D O I
10.1111/1467-985X.00166
中图分类号
O1 [数学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 0701 ; 070101 ;
摘要
The paper looks at the problem of comparing two treatments, for a particular population of patients, where one is the current standard treatment and the other a possible alternative under investigation. With limited (finite) financial resources the decision whether to replace one by the other will not be based on health benefits alone. This motivates an economic evaluation of the two competing treatments where the cost of any gain in health benefit is scrutinized; it is whether this cost is acceptable to the relevant authorities which decides whether the new treatment can become the standard. We adopt a Bayesian decision theoretic framework in which a utility function is introduced describing the consequences of making a particular decision when the true state of nature is expressed via an unknown parameter theta (this parameter denotes cost, effectiveness, etc.). The treatment providing the maximum posterior expected utility summarizes the decision rule, expectations taken over the posterior distribution of the parameter theta.
引用
收藏
页码:211 / 225
页数:15
相关论文
共 55 条
  • [51] FOUNDATIONS OF COST-EFFECTIVENESS ANALYSIS FOR HEALTH AND MEDICAL PRACTICES
    WEINSTEIN, MC
    STASON, WB
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1977, 296 (13) : 716 - 721
  • [52] Theoretical issues in cost-effectiveness analysis
    Weinstein, MC
    Manning, WG
    [J]. JOURNAL OF HEALTH ECONOMICS, 1997, 16 (01) : 121 - 128
  • [53] Weinstein MC., 1995, VALUING HLTH CARE CO
  • [54] WEINSTEIN MC, 1972, J PUBLIC ECON, V2, P716
  • [55] WILLIAMS A, 1990, HEALTH POLICY, V16, P199